Correction: A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery

Correction: A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-05-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/8/1/e000415corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus encoding IL-12
by: Cheyne Kurokawa, et al.
Published: (2024-03-01)

A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer
by: Lijuan Chen, et al.
Published: (2025-01-01)

Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safety
by: David L Bartlett, et al.
Published: (2020-05-01)

Oncolytic vaccinia virus harboring CLEC2A gene enhances viral replication and antitumor efficacy
by: Chunqing Gao, et al.
Published: (2024-09-01)

Oncolytic vaccinia virus armed with anti-CD47 nanobody elicit potent antitumor effects on multiple tumor models via enhancing innate and adoptive immunity
by: Jie Chen, et al.
Published: (2024-12-01)

Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer
by: Chang Woo Kim, et al.
Published: (2020-10-01)

A model of the artificial metastasis of human epidermoid carcinoma A431 in nude mice for examination of the oncolytic activity of vaccinia virus
by: G. V. Kochneva, et al.
Published: (2015-12-01)

Generation of novel oncolytic vaccinia virus with improved intravenous efficacy through protection against complement-mediated lysis and evasion of neutralization by vaccinia virus-specific antibodies
by: Dong-Sup Lee, et al.
Published: (2023-01-01)

An oncolytic vaccinia virus encoding hyaluronidase reshapes the extracellular matrix to enhance cancer chemotherapy and immunotherapy
by: Jie Dong, et al.
Published: (2024-03-01)

CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency
by: Yi Zhang, et al.
Published: (2020-05-01)

Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication
by: Eric Bartee, et al.
Published: (2020-05-01)

Specific Immune Responses and Oncolytic Effects Induced by EBV LMP2A-Armed Modified Ankara-Vaccinia Virus Vectored Vaccines in Nasopharyngeal Cancer
by: Liying Sun, et al.
Published: (2025-01-01)

Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma
by: Cristian Capasso, et al.
Published: (2016-04-01)

Mitochondrial metabolic reprogramming of macrophages and T cells enhances CD47 antibody-engineered oncolytic virus antitumor immunity
by: Ping Cheng, et al.
Published: (2024-12-01)

GM-CSF and IL-21-armed oncolytic vaccinia virus significantly enhances anti-tumor activity and synergizes with anti-PD1 immunotherapy in pancreatic cancer
by: Yujing Xuan, et al.
Published: (2025-01-01)

Polymeric immunogel prevents tumor recurrence and metastasis by dual activation of innate and adaptive immunity
by: Guanyu Jin, et al.
Published: (2025-03-01)

Durable antitumor response via an oncolytic virus encoding decoy-resistant IL-18
by: Yu Liu, et al.
Published: (2024-12-01)

Engineered oncolytic virus expressing B7H3-targeting BiTE enhances antitumor T-cell immune response
by: Ying Liu, et al.
Published: (2024-11-01)

Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer
by: Khin Thway, et al.
Published: (2020-10-01)

circ-1584 selectively promotes the antitumor activity of the oncolytic virus M1 on pancreatic cancer
by: Taofang Hao, et al.
Published: (2025-03-01)

Functional remodeling of intraperitoneal macrophages by oncolytic adenovirus restores anti-tumor immunity for peritoneal metastasis of gastric cancer
by: Motoyasu Tabuchi, et al.
Published: (2024-06-01)

Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunity
by: Tomoko Ohtani, et al.
Published: (2024-11-01)

The impact of innate immune response on the efficacy of oncolytic viruses
by: Kirill N. Trachuk, et al.
Published: (2024-12-01)

The replicability of oncolytic virus: Defining conditions in tumor virotherapy
by: Jianjun Paul Tian
Published: (2011-05-01)

Expression of GPX4 by oncolytic vaccinia virus can significantly enhance CD8+T cell function and its impact against pancreatic ductal adenocarcinoma
by: Wei Wei, et al.
Published: (2024-12-01)

Unveiling the nexus: Oncolytic viruses, extracellular vesicles, and immune modulation
by: Pierre Cordelier
Published: (2025-03-01)

4-1BBL-Armed Oncolytic Herpes Simplex Virus Exerts Antitumor Effects in Pancreatic Ductal Adenocarcinoma
by: Wenrui Gao, et al.
Published: (2024-11-01)

Enhancing antitumor efficacy of oncolytic virus M1 via albendazole-sustained CD8+ T cell activation
by: Wenjing Bai, et al.
Published: (2024-06-01)

Rational strategies for designing next-generation oncolytic viruses based on transcriptome analysis of tumor cells infected with oncolytic herpes simplex virus-1
by: Naeme Javid, et al.
Published: (2025-01-01)

Construction of chimeric IL-21 recombinant oncolytic influenza virus and mechanisms for its antitumor efficacy against hepatocellular carcinoma
by: CAO Rui, et al.
Published: (2024-12-01)

The implications of oncolytic viruses targeting fibroblasts in enhancing the antitumoural immune response
by: Ibrahem Al-Obaidi, et al.
Published: (2024-10-01)

Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity
by: Bora Lim, et al.
Published: (2024-12-01)

Mpox vaccination with live vaccinia virus: Essential guidance for dermatologists
by: Anna Ecanow, BS, et al.
Published: (2025-02-01)

Translation of oncolytic viruses in sarcoma
by: Steven I. Robinson, et al.
Published: (2024-09-01)

Neutrophils in oncolytic virus immunotherapy
by: Danya Zhou, et al.
Published: (2024-12-01)

Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis
by: Jia-Li Zhao, et al.
Published: (2024-11-01)

Comparison of differences in immune cells and immune microenvironment among different kinds of oncolytic virus treatments
by: Xiaoke Wu, et al.
Published: (2024-11-01)

Extracellular matrix re-normalization to improve cold tumor penetration by oncolytic viruses
by: Geofrey F. Soko, et al.
Published: (2025-01-01)

Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors
by: Selene Ingusci, et al.
Published: (2024-03-01)

PB101, a VEGF- and PlGF-targeting decoy protein, enhances antitumor immunity and suppresses tumor progression and metastasis
by: Eun-Jin Go, et al.
Published: (2023-12-01)